What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in ...

Inspire Medical Systems’ first quarter showed strong momentum, as results exceeded Wall Street’s expectations for both ...

Inspire Medical Systems Inc. research and ratings by Barron's. View INSP revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Inspire Medical Systems, Inc. announced preliminary fourth quarter and full year 2024 financial results, revealing anticipated revenues of approximately $239.5 million to $239.7 million for Q4, ...

Inspire Medical Systems, Inc. announced strong financial performance for the fourth quarter and full year of 2024, reporting a 25% increase in revenue for Q4, totaling $239.7 million, and a 28% ...

Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc ...

View the latest Inspire Medical Systems Inc. (INSP) stock price, news, historical charts, analyst ratings and financial information from WSJ.

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Inspire Medical Systems (INSP – Research Report), with a price target of $187.00. Larry Biegelsen has ...

Inspire Medical Systems is a rapidly growing medical technology company specializing in a device that treats Obstructive Sleep Apnea. The company is still in the early stages of developing their ...

Inspire Medical Systems (INSP 2.09%), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10.

If a traditional CPAP machine isn't for you, you might consider the Inspire sleep apnea device as an alternative treatment option. Here's what you need to know.